Status:

COMPLETED

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

Lead Sponsor:

Ain Shams University

Conditions:

Critical Illness

Pneumonia, Viral

Eligibility:

All Genders

Brief Summary

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

Detailed Description

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients. It has been reported that COVID 19 is associated with hem...

Eligibility Criteria

Inclusion

  • patients of both sex admitted in icu
  • positive PCR
  • requiring oxygen therapy

Exclusion

  • ward patients
  • negative PCR

Key Trial Info

Start Date :

June 10 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 9 2022

Estimated Enrollment :

465 Patients enrolled

Trial Details

Trial ID

NCT05279469

Start Date

June 10 2021

End Date

March 9 2022

Last Update

March 15 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Ain shams university hospitals

Cairo, Egypt

2

Faculty of medicine, Ain Shams University

Cairo, Egypt